A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

The most notorious was biting the head off a live bat while on stage in Iowa in 1982. He had been catapulting raw meat into ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A documentary on Ayurveda is trying to capture the movement of convergence between the ancient science and Western medicine ...

Parkinson’s disease diagnoses are rising across East Africa—hinting at a shift in healthcare priorities. Frank Burkybile reports One sunny afternoon in Nairobi a crowd of 200 patients, care givers, ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.